CorMedix Inc. (NASDAQ: CRMD)
$8.1800
-0.3900 ( -4.33% ) 294.1K
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Market Data
Open
$8.1800
Previous close
$8.5700
Volume
294.1K
Market cap
$508.48M
Day range
$8.1600 - $8.7680
52 week range
$2.8900 - $13.8500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4/a | Other | 1 | Dec 18, 2024 |
| 4 | Insider transactions | 1 | Dec 16, 2024 |
| 4 | Insider transactions | 1 | Dec 13, 2024 |
| 8-k | 8K-related | 13 | Nov 25, 2024 |
| 4 | Insider transactions | 1 | Nov 18, 2024 |
| 10-q | Quarterly Reports | 54 | Oct 30, 2024 |
| 8-k | 8K-related | 15 | Oct 30, 2024 |
| def | Proxies and info statements | 5 | Oct 08, 2024 |
| 10-q | Quarterly Reports | 55 | Aug 14, 2024 |
| 8-k | 8K-related | 15 | Aug 14, 2024 |